FCER2 and aspergillosis: Therefore, it indicated that PU.1-CD23 signaling pathway was critical regulator in anti-aspergillosis immunity by driving inflammation response, and may be a new anti-aspergillosis therapeutic for the future treatment of invasive aspergillosis.